AI Absorbed 80% of Global Venture Capital in Q1 2026. The Rest of the Market Is Competing for What's Left.

Written By Chelsie Cay Zhu

Venture capital has always concentrated around themes, but the 2026 numbers have moved past any previous definition of concentration.AI startups captured approximately 80% of all global venture capital in Q1 2026, according to CB Insights data, up from 48% in 2025 by CB Insights' count and 61% by the OECD's. In Q1 2026, AI crossed from a concentration story into something closer to a near-monopoly on new capital deployment.

The Numbers

AI startups raised $560 billion since 2022, with the top five AI companies reaching over $1.2 trillion in combined value, three times all dot-com era IPO value combined. OpenAI and Anthropic absorbed roughly 14% of every venture dollar invested worldwide in 2025. In Q1 2026, AI's share of global VC jumped from roughly half to four-fifths in a single quarter.

The implication for non-AI startups is direct: a fintech, a biotech, or a climate tech company raising a Series A in 2026 is competing for the remaining 20% of global venture capital against every other non-AI company in every sector in every geography.Institutional investors currently have zero interest in deals outside artificial intelligence, according to Bill Gurley speaking in late 2025, with solid companies in other sectors facing what he described as existential risk from being unable to secure follow-on funding.

What Is Driving the Concentration

Sovereign wealth funds, hyperscalers, and large crossover investors have moved directly into AI company financing at a scale that dwarfs traditional VC fund structures, and the concentration follows from that shift rather than from AI being uniquely attractive as a venture asset class. OpenAI's $122 billion round from SoftBank, Amazon, and Nvidia was sovereign wealth-class capital treating frontier AI infrastructure as a strategic national asset, deployed through structures that bypass LP-to-GP fundraising entirely.

Kleiner Perkins launched a $3.5 billion fund dedicated exclusively to AI startups, one of the largest AI-focused venture vehicles ever raised by a single firm, because the fund economics require AI exposure to remain competitive in LP conversations. The feedback loop compounds: AI companies attract capital because they attract capital, and the managers who raise money are the ones with AI theses.

The geographic dimension adds another layer.Q1 2026 European venture investment hit $17.6 billion, up 30% year-on-year, with AI reaching 50% of EU VC funding for the first time. The bifurcation between AI and non-AI is not a US phenomenon, playing out identically across every major venture market globally. European deep tech, climate, and industrial AI are capturing the AI-tagged dollars; everything else is competing for the remainder.

Where the Remaining 20% Is Going

The 20% of capital not going to AI is concentrated in three areas:

The sectors losing out are the ones without a clear AI connection: traditional fintech without an AI layer, consumer software in mature categories, B2B SaaS where the AI story is thin. Those companies are competing for less capital in a fundraising environment where their investor base has partially redirected attention elsewhere.

What this means practically:the venture market in 2026 is the most bifurcated it has been in a decade, and the bar for companies raising outside the AI consensus is roughly what it was in 2017 with a higher diligence threshold. Partners are saying no faster, and the deals that clear are the ones with genuine platform differentiation, not incremental category improvement.

The Biotech and Climate Picture

The human cost of concentration is most visible in biotech and climate, two sectors that have historically attracted significant venture capital on long-duration investment theses.

SVB's Healthcare Investments and Exits H1 2026 report shows healthcare VC in an AI surge amid a broader fundraising slump. AI-enabled healthtech is capturing investment while traditional biotech faces the same structural headwinds as every non-AI category. Climate tech is in a similar position: companies without an AI angle or a direct connection to data centre energy demand are finding it significantly harder to raise than they were 18 months ago.

The irony is that both biotech and climate tech represent investment categories where long holding periods and capital intensity have always required patient capital, exactly the characteristics that should align with private market investment mandates. The current market is prioritising AI trajectory over long-duration category bets, which creates an unusual dynamic for fund managers who built their track records in those sectors.

The Wellington and PitchBook Context

Both the Wellington midyear outlook and the PitchBook Q2 2026 Venture Monitor flagged the same dynamic: concentration at the top creates less efficient segments below, which historically creates conditions for differentiated returns in less-trafficked parts of the market. The 80% AI figure is the most extreme version of that concentration yet, and it makes the barbell argument for investing in the underfollowed segments more empirically grounded than it has been at any point in the past decade.

NonPublic Pty Ltd (ABN 49 607 216 928) holds Australian Financial Services Licence #482668. Investments are available to wholesale and sophisticated investors as defined under the Corporations Act 2001. This content is general in nature and does not constitute financial product advice. It does not take into account your objectives, financial situation, or needs. Investing in private markets involves significant risk, including the potential loss of your entire investment. Past performance is not a reliable indicator of future results. You should obtain independent financial advice before making any investment decision.

Chelsie Cay Zhu
Next

OpenAI's IPO Timeline Keeps Shifting. Here Is What the Current State of Play Actually Looks Like.